Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice
Respiratory syncytial virus (RSV) is the most common cause of small airways inflammation in the lungs (bronchiolitis) in neonates and immunocompromised adults. The deregulation of cellular and plasma components leads to increased morbidity and mortality. The activation of the clotting cascade plays...
Saved in:
Main Authors: | Zhuang Shihao, Tang Qiuyu, Chen Ping, Wang Chengyi, Liu Guanghua |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-09-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2022-0022 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recommendation for the use of respiratory syncytial virus vaccines
by: Ping-Ing Lee, et al.
Published: (2025-02-01) -
Role of bovine respiratory syncytial virus in etiology of respiratory diseases on milk farms
by: S. V. Koteneva, et al.
Published: (2021-03-01) -
Circulation of Respiratory Syncytial Virus (RSV) in Poland Between Seasons of 2009/2010 and 2022/2023 Based on SENTINEL System
by: Karol Szymański, et al.
Published: (2025-01-01) -
Prevalence of Respiratory Syncytial Virus Infection in Hospitalized COPD Patients in Spain Between 2018–2022
by: Rosa María Gómez-García, et al.
Published: (2025-01-01) -
Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant
by: Teresa Jackowska, et al.
Published: (2024-12-01)